AI21 Labs updated the cookie and tracking section of their Terms of Use on April 30, 2026. The changes shift the language around cookies and tracking technologies, introduce a clearer opt-out mechanism for targeted advertising and sale of personal data, and add more detail about strictly necessary cookies that cannot be disabled. This matters because users now have an explicit opt-out right for data sale and targeted advertising, but also lose some previously available cookie management flexibility.
AI21 Labs has updated its cookie consent framework to introduce an explicit opt-out right for the sale of personal data and targeted advertising, replacing the previous general cookie acceptance model. The language now clarifies that strictly necessary cookies cannot be turned off, while other cookie types can be managed — and that restricting certain cookies may affect your site experience. You can exercise your right to opt out of the sale of your personal data and targeted advertising by clicking the 'Your Opt-Out Rights' button on AI21 Labs' website.
You now have a specific button to click if you don't want AI21 Labs to sell your data or use it for targeted ads.
Some cookies on AI21 Labs' site are mandatory and you cannot turn them off, even if you adjust your cookie preferences.
+ 1 more obligation changes. Full breakdown available with Watcher.
Unlock — $9.99/mo →The addition of an explicit opt-out for data sale and targeted advertising gives users a meaningful new privacy control, particularly important for California residents under CPRA. However, the removal of the assurance that cookie data does not directly identify users is a subtle but notable weakening of privacy language.
A new explicit opt-out mechanism ('Your Opt-Out Rights') has been added for users to opt out of the sale of personal data and targeted advertising, directly addressing CCPA/CPRA requirements.
New language clarifies that strictly necessary cookies cannot be disabled by users, narrowing the scope of user control over cookie settings.
The stated purpose of cookie data collection has been expanded to include providing a 'more personalized web experience,' broadening the disclosed use of collected data.
ConductAtlas Policy Archive Entity: AI21 Labs | Document: AI21 Labs Terms of Use | Record: CA-C-000739 Captured: 2026-04-30 06:39:09 UTC URL: https://conductatlas.com/change/2026-04-30-ai21-labs-ai21-labs-terms-of-use-739/ Accessed: May 2, 2026
Unlock the full analysis
14-day free trial available.
AI21 Labs has updated its cookie consent and tracking disclosure language on April 30, 2026 in ways that appear to align with CCPA/CPRA opt-out-of-sale obligations (Cal. Civ. Code §1798.120) and GDPR consent requirements (Art. 6, 7, and Recital 32). The addition of a dedicated 'Your Opt-Out Rights' mechanism and explicit language about sale of personal data and targeted advertising suggests a response to CPRA enforcement requirements effective since 2023. Organizations with AI21 Labs in their vendor stack should confirm their own privacy notices reflect any downstream data flows implicated by targeted advertising. Compliance review is warranted but not urgent.
1. CCPA/CPRA — Cal. Civ. Code §1798.120 (right to opt out of sale of personal information) and §1798.135 (requirement to post 'Do Not Sell or Share My Personal Information' link): The new 'Your Opt-Out Rights' button and explicit opt-out-of-sale language directly addresses this requirement. Cal. Civ. Code §1798.100 (general consumer rights) also relevant. CPRA enforcement by the California Privacy Protection Agency (CPPA) has prioritized opt-out mechanisms.
Compliance intelligence locked
Obligation analysis, escalation trigger, board language, and recommended action.
Watcher: regulatory citations + obligations. Professional: full compliance memo.
ConductAtlas provides verified policy intelligence sourced directly from platform documents. All analysis is intended to support, not replace, legal and compliance review. Record CA-C-000739.
Severity increased from high to high, but the provision text remains identical; the actual change is the severity rating elevation from medium to high.
9 provisions unchanged.
Cross-platform context
See how other platforms handle similar provisions across the ConductAtlas archive.
See the full side-by-side comparison of every sentence added, removed, and modified.
🔒 Unlock full diff — Watcher $9.99/moWe monitor 200+ platforms and archive every change — verified and timestamped.